106612-94-6

106612-94-6 structure
106612-94-6 structure
  • Name: GLP-1 (7-37)
  • Chemical Name: h-his-ala-glu-gly-thr-phe-thr-ser-asp-val-ser-ser-tyr-leu-glu-gly-gln-ala-ala-lys-glu-phe-ile-ala-trp-leu-val-lys-gly-arg-gly-oh
  • CAS Number: 106612-94-6
  • Molecular Formula: C151H228N40O47
  • Molecular Weight: 3355.666
  • Catalog: Biochemical Peptide
  • Create Date: 2018-05-24 08:00:00
  • Modify Date: 2026-06-30 11:46:20
  • GLP-1(7-37) is an intestinal insulinotropic hormone that augments glucose induced insulin secretion. Sequence: His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly.

Name h-his-ala-glu-gly-thr-phe-thr-ser-asp-val-ser-ser-tyr-leu-glu-gly-gln-ala-ala-lys-glu-phe-ile-ala-trp-leu-val-lys-gly-arg-gly-oh
Synonyms H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-G-GLY-OH //BP
GLP-1, Insulinotropin
TIANFUCHEM-106-6--H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-G-GLY-OH
Proglucagon (huMan, bovine, guinea pig, Mouse, rat), Glucagon-Like Ptide 1 (huMan, bovine, guinea pig, Mouse, rat), Insulinotropin (huMan, bovine, guinea pig, Mouse, rat), Prroglucagon (huMan, bovine, guinea pig, Mouse, rat)
GLP-1 (HUMAN, ) (BOVINE, CANINE, RAT, GUINEA PIG)
Tglp-1
PRROGLUCAGON HUMAN
GLP-1 , Human, Mouse, Rat, Bovine, Guinea Pig
GLP-1 acetate salt
GLP-1(7-37)
Glp-I
Glucagon like ptide I
GLUCAGON-LIKE PTIDE 1
PROGLUCAGON (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT)
HuMan GLP-1
Glucagon-Like Ptide (GLP) I
Insulinotropin (human)
Prroglucagon
PREPROGLUCAGON 78-108 HUMAN
H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR- LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-LE-ALA-TRP-LEU-VAL- LYS-GLY-G-GLY-OH
GLP-1 (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT)
GLUCAGON LIKE PTIDE-I , HUMAN
H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GL
GLP-1 (huMan, bovine, guinea pig, Mouse, rat) Proglucagon (huMan, bovine, guinea pig, Mouse, rat), Insulinotropin (huMan, bovine, guinea pig, Mouse, rat), Glucagon-Like Ptide 1 (huMan, bovine, guinea pig, Mouse, rat), Prroglucag
GLP-1 Prroglucagon
GLUCAGON-LIKE PTIDE 1, FRAGMENT HUMAN
HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-G-GLY
H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-g-Gly-OH acetate salt
GLUCAGON-LIKE PTIDE 1 (HUMAN, ) (BOVINE, CANINE, RAT, GUINEA PIG)
Glucagon-related ptide (oncorhynchus kisutch), 3-L-glutamic acid-6-L-phenylalanine-9-L-asptic acid-12-L-serine-15-L-glutamic acid-16-glycine-21-L-isoleucine-24-L-alanine-27-L-valine-28-L-lysine-31-glycine
GLUCAGON-LIKE PTIDE 1 (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT)
INSULINOTROPIN (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT)
Preproglucagon 78-108
L-Histidyl-L-alanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycyl-L-glutaminyl-L-alanyl-L-alany
 l-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-lysylglycyl-N-(diaminomethylene)-L-ornithylglycine
Glucagon-liktide
GLP-1 impurity
Glucagon-Like Ptide-1 |GLP-1 (human, bovine, guinea pig, mouse, rat)
l-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alany
Insulinotropin acetate [GLP-1
Glucagon-like ptide I (human)
GLP-1 (7-37) Acetate
HAEGTFTSDVSSYLEGQAAKEFIAWLVKG
GLP-1
GLUCAGON-LIKE PTIDE 1 (HUMAN)
Proglucagon (huMan, bovine, guinea pig, Mouse, rat), Insulinotropin (huMan, bovine, guinea pig, Mouse, rat), Glucagon-Like Ptide 1 (huMan, bovine, guinea pig, Mouse, rat), Prroglucagon (huMan, bovine, guinea pig, Mouse, rat)
PRROGLUCAGON (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT)
GLP-1 (HUMAN)
HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-ARG-GLY
(5S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,50S,53S,56S,59S,62S,65S,68S,71S,74S,77S,80S,86S)-20-((1H-Indol-3-yl)methyl)-86-((S)-2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)propanamido)-44-(3-amino-3-oxopropyl)-11,35-bis(4-aminobutyl)-29,77-dibenzyl-26-((S)-sec-butyl)-32,50-bis(2-cboxyethyl)-68-(cboxymethyl)-5-(3-guanidinopropyl)-56-(4-hydroxybenzyl)-74,80-bis((R)-1-hydroxyethyl)-59,62,71-tris(hydroxymethyl)-17,53-diisobutyl-14,65-diisopropyl-23,38,41-trimethyl-4,7,10,13,16,19,22,2
GLP-1,HAEGTFTSDVSSYLEGQAAKEFIAWLVKG
insulinotropin
H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-G-GLY-OH
GLP-1 Acetate | Glucagon-Like Ptide 1
Human GLP-1
Human GLP-1 (7-37)
Glucagon-Like Ptide 1, GLP-1 human, mouse, rat, bovine, guinea pig
(5S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,50S,53S,56S,59S,62S,65S,68S,71S,74S,77S,80S,86S)-20-((1H-Indol-3-yl)methyl)-86-((S)-2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)propanamido)-44-(3-amino-3-oxopropyl)-11,35-bis(4-aminobutyl)-29,77-dibenzyl-26-((S)-sec-butyl)-32,50-bis(2-cboxyethyl)-68-(cboxymethyl)-5-(3-guanidinopropyl)-56-(4-hydroxybenzyl)-74,80-bis((R)-1-hydroxyethyl)-59,62,71-tris(hydroxymethyl)-17,53-diisobutyl-14,65-diisopropyl-23,38,41-trimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82,85-octacosaoxo-3,6,9,12,15,18,21,24,27,30
Ptide GLP-1 (human glucose-lowering ptide-1)
GLP-1,7-37
Description GLP-1(7-37) is an intestinal insulinotropic hormone that augments glucose induced insulin secretion. Sequence: His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly.
Related Catalog
In Vivo GLP-1(7-37) is an intestinal insulinotropic hormone that augments glucose induced insulin secretion[1]. An intravenous (IV) infusion of GLP-1(7-37) at 0.5, 5, or 50 pmol/min/kg during the second hour of a 2-hour 11-mmol/L hyperglycemic clamp in Sprague-Dawley rats produces a dose-related enhancement of the glucose-induced increase in plasma insulin concentration. Infusion of GLP-1(7-37) (5 pmol/min/kg IV) during a hyperglycemic clamp at two sequentially increasing concentrations of glucose, 11 and 17 mmol/L, produces incremental increases in insulin of 600 and 1,200 pM, respectively. Similarly, infusion of GLP-1(7-37) in hyperinsulinemic, hyperglycemic Zucker diabetic fatty (ZDF) rats produces a transitory increase in plasma insulin concentration and normalizes the plasma glucose concentration. Infusion of GLP-1(7-37) in rats maintains at 11 mM glucose results in a sustained approximately twofold enhancement of the plasma insulin concentration. In rats infused with GLP-1(7-37) for 5 days at 15 pmol/min/kg, there is a small increase in basal plasma insulin concentration and no effect on glucose[2].
Animal Admin Rats[2] All experiments are conducted in conscious, catheterized, male Sprague-Dawley rats weighing 300 to 350 g or control rats (body weights, 280 to 320 and 220 to 260 g, respectively). GLP-1(7-37) is infused at 0.5, 5, or 50 pmol/min/kg IV during the second hour of a 2-hour 11-mM hyperglycemic clamp. Glucose (50% solution) is infused at a variable rate to maintain plasma glucose concentration at 11 mM. GLP-1(7-37) (5 pmol/rnin/kg) or vehicle (2% heat-inactivated serum plus 1% sodium acetate in normal saline) is infused via the jugular catheter for 60 minutes[2].
References

[1]. Sarrauste de Menthiere, C. et al. Structural requirements of the N-terminal region of GLP-1-[7-37]-NH2 for receptor interaction and cAMP production. European journal of medicinal chemistry 39, 473-480, doi:10.1016/j.ejmech.2004.02.002 (2004).

[2]. Hargrove DM, et al. Glucose-dependent action of glucagon-like peptide-1 (7-37) in vivo during short- or long-term administration. Metabolism. 1995 Sep;44(9):1231-7.

Density 1.5±0.1 g/cm3
Molecular Formula C151H228N40O47
Molecular Weight 3355.666
Exact Mass 3353.667969
PSA 1408.40000
LogP -3.86
Index of Refraction 1.660
Storage condition −20°C
Water Solubility Soluble in water at 2mg/ml
Safety Phrases 22-24/25
WGK Germany 3
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.